Chimeric Antigen Receptor T Cells in Multiple Myeloma

被引：1
|
作者：
Shah, Parth [1 ,2 ,4 ]
Sperling, Adam S. [2 ,3 ]
机构：
[1] Dartmouth Canc Ctr, Dept Hematol, 1 Med Ctr Dr, Lebanon, NH 03750 USA
[2] Dana Farber Canc Inst, Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA
[4] 1 Med Ctr Dr, Lebanon, NH 03750 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
Multiple myeloma; CAR-T; BCMA; GPRC5D; BiTEs; THERAPY; BCMA; MALIGNANCIES; MATURATION; ANTIBODY; COMBINATION; TRANSPLANT; EXPRESSION; PHASE-1; FUSION;
D O I：
10.1016/j.hoc.2023.05.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1089 / 1105
页数：17
相关论文
共 50 条
  • [21] Chimeric antigen receptor T cell therapies for multiple myeloma
    Chao Wu
    Lina Zhang
    Qierra R. Brockman
    Fenghuang Zhan
    Lijuan Chen
    Journal of Hematology & Oncology, 12
  • [22] Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma
    Hamadeh, Issam S.
    Friend, Reed
    Mailankody, Sham
    Atrash, Shebli
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [23] Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
    Tiantian Ma
    Jing Shi
    Huasheng Liu
    Annals of Hematology, 2019, 98 : 813 - 822
  • [24] Enhanced antitumor efficacy, proliferative capacity, and alleviation of T cell exhaustion by fifth-generation chimeric antigen receptor T cells targeting B cell maturation antigen in multiple myeloma
    Yuti, Pornpimon
    Sawasdee, Nunghathai
    Natungnuy, Krissada
    Rujirachaivej, Punchita
    Luangwattananun, Piriya
    Sujjitjoon, Jatuporn
    Yenchitsomanus, Pathai
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [25] Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
    Hosen, Naoki
    CANCERS, 2019, 11 (12)
  • [26] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Hosen, Naoki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 530 - 534
  • [27] Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myeloma
    Beauvais, David
    Danhof, Sophia
    Hayden, Patrick J.
    Einsele, Hermann
    Yakoub-Agha, Ibrahim
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (05) : 418 - 426
  • [28] Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma
    Atrash, Shebli
    Ali, Syed Abbas
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01) : 21 - 34
  • [29] Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma Moving Into the Spotlight
    Wang, Bo
    Rajeeve, Sridevi
    Madduri, Deepu
    CANCER JOURNAL, 2021, 27 (03) : 205 - 212
  • [30] Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma
    Huang, He
    uW, Heng-wei
    Hu, Yong-xian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (01): : 29 - 41
12345